Cargando…

Ganciclovir use evaluation in kidney transplantation departments

OBJECTIVE: In this study, we evaluated certain aspects of the usage and administration of one lifesaving, high-cost medication, i.e., Ganciclovir for the prevention and treatment of cytomegalovirus (CMV) infection in transplant patients. METHODS: This study was performed from 2013 to 2015 by conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mozaffar, Maryam, Shahidi, Shahrzad, Badri, Shirinsadat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966242/ https://www.ncbi.nlm.nih.gov/pubmed/27512714 http://dx.doi.org/10.4103/2279-042X.185742

Ejemplares similares

Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
por: Mozaffar, Maryam, et al.
Publicado: (2018)

Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
por: Shahraki, Tahereh Gholipur, et al.
Publicado: (2020)

Acute Kidney Injury in the ICU during Ganciclovir Treatment, an Observational Study
por: Al Fartousi, Mina, et al.
Publicado: (2023)

Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014)

Ganciclovir therapeutic drug monitoring in transplant recipients
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
por: Menghi, Viola, et al.
Publicado: (2016)

Molecular Detection and Genotyping of Human Cytomegalovirus in Kidney Transplant Recipients under Ganciclovir Prophylaxis in Iran
por: Behnezhad, Farzane, et al.
Publicado: (2022)

Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation
por: Ding, Zhaoqing, et al.
Publicado: (2014)

Outcome of Rapamycin Therapy for Post-Transplant-Lymphoproliferative Disorder after Kidney Transplantation: Case Series
por: Ashrafi, Farzaneh, et al.
Publicado: (2015)

Herbal Supplement Use and Herb–drug Interactions among Patients with Kidney Disease
por: Mohammadi, Soroush, et al.
Publicado: (2020)

Combined Heart and Kidney Transplantation: Initial Clinical Experience
por: Atik, Fernando Antibas, et al.
Publicado: (2022)

Risk aversion in the use of complex kidneys in paired exchange programs: Opportunities for even more transplants?
por: Roll, Garrett R., et al.
Publicado: (2022)

Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)

The side effect profile of sirolimus and its relationship with some variables: A retrospective study of Iranian renal transplant patients
por: Shahidi, Shahrzad, et al.
Publicado: (2023)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
por: Wong, Diana D., et al.
Publicado: (2022)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

Risk Factors for Erythrocytosis in Renal Transplantation: Is Ganciclovir Therapy One of Them?
por: Koçak, Fatma Özge Kayhan, et al.
Publicado: (2022)

Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
por: Marfil, Sjanene, et al.
Publicado: (2023)

Survival of Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment
por: Ashrafi, Farzaneh, et al.
Publicado: (2021)

A desensitization protocol to ganciclovir
por: Cernadas, Josefina Rodrigues, et al.
Publicado: (2014)

Lower versus higher starting tacrolimus dosing in kidney transplant recipients
por: Chua, Justin C. M., et al.
Publicado: (2022)

Outcomes of COVID-19 in Kidney Transplant Recipients: The Sri Lankan Experience
por: Wijayaratne, Dilushi, et al.
Publicado: (2023)

Effects of Carnitine on Nutritional Parameters in Patients with Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis
por: Gholipur-Shahraki, Tahereh, et al.
Publicado: (2018)

Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients
por: Rho, Elena, et al.
Publicado: (2021)

Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic
por: Berteloot, Laureline, et al.
Publicado: (2021)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
por: Ahn, Jin Hee, et al.
Publicado: (1999)

Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
por: Holmes-Liew, Chien-Li, et al.
Publicado: (2015)

Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
por: Fang, Hu, et al.
Publicado: (2022)

Therapeutic drug monitoring of vancomycin by AUC(τ)-MIC ratio in patients with chronic kidney disease
por: Khoei, Ahmad, et al.
Publicado: (2019)

Potential Benefits of Selenium Supplementation in Patients with Kidney Disease
por: Badri, Shirinsadat, et al.
Publicado: (2022)

Impact of having potential living donors on ethnic/racial disparities in access to kidney transplantation
por: Gordon, Elisa J., et al.
Publicado: (2022)

Assessment of Pediatric Kidney Transplant Experience and Exposure During Pediatric Nephrology Fellowship Training
por: Spiwak, Elizabeth, et al.
Publicado: (2023)

Designing, implementing, and evaluating the process of training advisor and teaching assistant at Isfahan medical school
por: Shahidi, Shahrzad, et al.
Publicado: (2021)

Homocysteine-Lowering Interventions in Chronic Kidney Disease
por: Badri, Shirinsadat, et al.
Publicado: (2021)

Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction
por: Taheri, Shahram, et al.
Publicado: (2011)

Crystallization after intravitreal ganciclovir injection
por: Choopong, Pitipol, et al.
Publicado: (2010)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients
por: Moudgil, Asha, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community
por: Strauss, Alexandra T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dceqislnvtsvfal0rqjjhtmroa